Skip to content

Careers Contact

Company

View overview →

Vision & mission→Leadership→Our history→Institutional investors→

Science & pipeline

Science & pipeline

View overview →

Development pipeline→Clinical evidence→Protein platform→Development & manufacturing→AI-assisted discovery→Research library→

Medicine resources

Investors

Investor overview →

Financial reports→Announcements & circulars→Governance→Listing documents→Corporate communications→IR contact→

Company→Science & pipeline→Medicine resources→Investors→News→

Careers Contact

Listing documents

Innogen’s Hong Kong listing prospectus, in its issued Chinese and English editions.

Financial reports→Announcements & circulars→Listing documents→Governance→Communications→Investor contact→

Loading disclosures…

Focused on diabetes and metabolic diseases

HKEX 02591

Company Science & pipeline Medicine resources Investors News Careers Contact

Contact Innogen

Follow Innogen on WeChat

Scan with WeChat.

info@innogenpharm.com ↗

399 Haiyang West Road, Pudong, Shanghai
21st Floor, Qiantan Times Square

Adverse events, complaints and inquiries400-004-0060

Drug_safety.postmarketing@innogenpharm.com ↗

© 2026 Innogen
Public security filing: 31011502013055 ↗ · ICP: 沪ICP备16021048号-1 ↗